Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 11
Submit an article Journal homepage
270
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia

Hemant MalhotraDivision of Medical Oncology, Department of Medicine, SMS Medical College, Jaipur, IndiaCorrespondence[email protected]
,
Pratibha SharmaDivision of Medical Oncology, Department of Medicine, SMS Medical College, Jaipur, India;Department of Zoology, University of Rajasthan, Jaipur, India
,
Shipra BhargavaDepartment of Zoology, University of Rajasthan, Jaipur, India;Department of Botany, University of Rajasthan, Jaipur, India
,
Om Singh RathoreDivision of Medical Oncology, Department of Medicine, SMS Medical College, Jaipur, India
,
Bharti MalhotraDepartment of Microbiology, SMS Medical College, Jaipur, India
&
Madhu KumarDepartment of Zoology, University of Rajasthan, Jaipur, India
Pages 2614-2619 | Received 12 Oct 2013, Accepted 14 Jan 2014, Published online: 07 Mar 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Harivenkatesh Natarajan, Lalit Kumar, Sameer Bakhshi, Atul Sharma, Thirumurthy Velpandian, Madhulika Kabra, Ajay Gogia, Nihar Ranjan Biswas & Yogendra Kumar Gupta. (2019) Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Leukemia & Lymphoma 60:2, pages 418-425.
Read now
Teoman Soysal, Ahmet Emre Eskazan & Muhlis Cem Ar. (2014) Generics in chronic myeloid leukemia: current arguments for and against and the established evidence. Expert Review of Hematology 7:6, pages 697-699.
Read now

Articles from other publishers (10)

Josephine A. Adattini, Jeffry Adiwidjaja, Annette S. Gross & Andrew J. McLachlan. (2023) Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia. Pharmacology Research & Perspectives 11:4.
Crossref
Alaa Sabri, Mervat M. Omran, S.Abdel Azim, Raafat Abdelfattah, Rasha Mahmoud Allam & Samia A. Shouman. (2023) A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients. Drug Research.
Crossref
Josephine A. Adattini, Annette S. Gross, Nicole Wong Doo & Andrew J. McLachlan. (2022) Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience. Pharmacology Research & Perspectives 10:5.
Crossref
William A. Clarke, Etienne Chatelut, Alan K. Fotoohi, Richard A. Larson, Jennifer H. Martin, Ron H.J. Mathijssen & Salvatore J. Salamone. (2021) Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy. European Journal of Cancer 157, pages 428-440.
Crossref
Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan & Ahmet Emre Eşkazan. (2021) Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs. Blood Advances 5:17, pages 3344-3353.
Crossref
Bharathi M. Rajamani, Esther Sathya Bama Benjamin, Aby Abraham, Sukanya Ganesan, Kavitha M. Lakshmi, Senthamizhselvi Anandan, Sreeja Karathedath, Savitha Varatharajan, Ezhilpavai Mohanan, Nancy Beryl Janet, Vivi M. Srivastava, Shaji Ramachandran Velayudhan, Uday P. Kulkarni, Anup J. Devasia, N. A. Fouzia, Anu Korula, Biju George, Alok Srivastava, Vikram Mathews & Poonkuzhali Balasubramanian. (2020) Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients. Scientific Reports 10:1.
Crossref
Laura Smy, Aaron J. SadlerGwendolyn A. McMillin. (2020) Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing—Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?. Therapeutic Drug Monitoring 42:4, pages 559-564.
Crossref
Hemant MalhotraJerald Radich & Pat Garcia-Gonzalez. (2019) Meeting the needs of CML patients in resource-poor countries. Hematology 2019:1, pages 433-442.
Crossref
Verena S. Hoffmann, Joerg Hasford, Michael Deininger, Jorge Cortes, Michele Baccarani & Rüdiger Hehlmann. (2017) Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology 143:7, pages 1311-1318.
Crossref
Jan H. Beumer, Daniel Kozo, Rebecca L. Harney, Caitlin N. Baldasano, Justin Jarrah, Susan M. Christner, Robert Parise, Irina Baburina, Jodi B. Courtney & Salvatore J. Salamone. (2015) An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma. Therapeutic Drug Monitoring 37:4, pages 486-492.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.